ASHLAND INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2014-12-11: Form 8-K/A; Period of report 2014-12-01; Description 8.01 Other Events.
- 2014-12-01: Form 8-K; Period of report 2014-12-01; Description 8.01 Other Events; Details 8.01.
- 2014-11-17: Form 8-K; Period of report 2014-11-12; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2014-11-17: Form 8-K; Period of report 2014-11-12; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2014-12-11 | 8-K/A | 2014-12-01 | 8.01 Other Events | form8ka.htm | |
| 2014-12-01 | 8-K | 2014-12-01 | 8.01 Other Events | 8.01 On December 1, 2014, Ashland Inc. (the “Company”) completed the previously announced sale of its elastomers business, based in Port Neches, Texas, to Lion Copolymer Holdings, LLC. | form8k.htm |
| 2014-11-17 | 8-K | 2014-11-12 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On November 14, 2014, Ashland Inc. (the “Company”) announced that its Chairman and Chief Executive Officer, James J. O’Brien, will retire effective December 31, 2014 pursuant to the Company’s previously announced succession and strategic plan. | form8k.htm |
| 2014-11-17 | 8-K | 2014-11-12 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 John F. Turner, whose term as a director expires in 2015, and having reached his 72nd birthday will retire from Ashland Inc.’s Board of Directors (the “Board) at the Annual Meeting pursuant to Ashland’s Corporate Governance Guidelines after nine years of service. | form8k.htm |
| 2014-11-17 | 8-K | 2014-11-17 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | form8k.htm | |
| 2014-11-05 | 8-K | 2014-11-05 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 On November 5, 2014, Ashland Inc. (“Ashland”) announced preliminary fourth quarter results, which are discussed in more detail in the news release (the “News Release”) attached to this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1, which is incorporated by reference into this Item 2.02. 7.01 On November 5, 2014, Ashland will make available the News Release, a slide presentation and prepared remarks on the “Investor Center” section of Ashland’s website located at http://investor.ashland.com. | form8k.htm |
| 2014-10-09 | 8-K | 2014-10-09 | 8.01 Other Events | 8.01 On October 9, 2014, Ashland Inc. (“Ashland”) and Lion Copolymer Holdings, LLC (“Lion Copolymer”) announced that they have entered into a definitive agreement under which Lion Copolymer will purchase Ashland’s elastomers business based in Port Neches, Texas. | form8k.htm |
| 2014-08-06 | 8-K | 2014-07-31 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 On July 31, 2014, Ashland Inc. (“Ashland”) completed the previously announced sale of its water technologies business conducted by the segment of Ashland known as “Ashland Water Technologies” to an entity formed and controlled by an affiliate of Clayton, Dubilier & Rice, LLC pursuant to the terms of the Sale and Asset Purchase Agreement, dated February 18, 2014, as amended from time to time, by and between Ashland and Solenis International, L.P. (f/k/a CD&R Seahawk Bidco, LLC). | form8k.htm |
| 2014-08-06 | 8-K | 2014-08-05 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 On August 5, 2014, Ashland Inc. (“Ashland”) entered into uncollared accelerated share repurchase agreements (each, an “ASR Agreement”) with each of Deutsche Bank AG, London Branch (“Deutsche Bank”) and J.P. Morgan Securities LLC, as agent for JPMorgan Chase Bank, N.A. (“JPMorgan”) to repurchase an aggregate of $750 million of Ashland’s common stock. 8.01 On August 6, 2014, Ashland announced that it has established Rule 10b5-1 trading plans with each of Deutsche Bank Securities Inc. (“Deutsche Bank Securities”) and J.P. Morgan Securities LLC (“JPMorgan Securities”) to repurchase an aggregate of $250 million of Ashland’s common stock in accordance with the guidelines specified under Rule 10b5-1 under the Securities Exchange Act, as amended. | form8k.htm |
| 2014-08-01 | 8-K | 2014-07-28 | 1.01 Entry into a Material Definitive Agreement | 1.01 In connection with the sale by Ashland Inc. (“Ashland”) of its Ashland Water Technologies business (the “Business”) to a fund managed by Clayton, Dubilier & Rice, LLC, which closed on July 31, 2014, Ashland amended the Transfer and Administration Agreement and the Sale Agreement (collectively, the “A/R Agreements”) of its Accounts Receivable Securitization Facility to remove receivables related to the Business, reduce the size of the facility to $275 million and make other minor conforming amendments to the Agreements. | form8k.htm |
| 2014-08-01 | 8-K | 2014-07-31 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 On July 31, 2014, Ashland Inc. (“Ashland”) completed the previously announced sale of its water technologies business conducted by the segment of Ashland known as “Ashland Water Technologies” (the “Business”) to an entity formed and controlled by an affiliate of Clayton, Dubilier & Rice, LLC pursuant to the terms of the Sale and Asset Purchase Agreement, dated February 18, 2014, as amended from time to time (the “Agreement”), by and between Ashland and Solenis International, L.P. (f/k/a CD&R Seahawk Bidco, LLC) (the “Buyer”) for a purchase price of approximately $1,790 million in cash, plus the assumption of certain liabilities of the Business as specified in the Agreement. | form8k.htm |
| 2014-07-31 | 8-K | 2014-07-31 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 On July 31, 2014, Ashland Inc. (“Ashland”) announced preliminary third quarter results, which are discussed in more detail in the news release (the “News Release”) attached to this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1, which is incorporated by reference into this Item 2.02. 7.01 On July 31, 2014, Ashland will make available the News Release, a slide presentation and prepared remarks on the “Investor Center” section of Ashland’s website located at http://investor.ashland.com. | form8k.htm |
| 2014-07-18 | 8-K | 2014-07-16 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 As a result of a request for proposal process undertaken by the Audit Committee of the Board of Directors (the “Audit Committee”) of Ashland Inc. (“Ashland” or the “Company”), on July 16, 2014, the Audit Committee appointed Ernst & Young LLP (“EY”) as Ashland’s independent registered public accounting firm for the fiscal year ending September 30, 2015, effective immediately following the Company’s filing of its Annual Report on Form 10-K for the year ending September 30, 2014. | form8k.htm |
| 2014-07-03 | 8-K | 2014-07-03 | 7.01 Regulation FD Disclosure | 7.01 As previously announced, upon the consummation of the sale of its Water Technologies business, Ashland Inc. (“Ashland”) will have three commercial units: Specialty Ingredients, Performance Materials and Valvoline (formerly Consumer Markets). | form8k.htm |
| 2014-07-01 | 8-K | 2014-07-01 | 8.01 Other Events | 8.01 On June 30, 2014, Ashland Inc. (“Ashland”) and Clariant Corp. (“Clariant”) completed the previously announced sale of their joint venture, ASK Chemicals GmbH (“ASK Chemicals”) headquartered in Hilden, Germany, to investment funds affiliated with Rhône Capital, LLC, a London and New York-based private equity investment firm (the “Sale”), pursuant to the terms of the Sale and Purchase Agreement, dated April 8, 2014, as amended from time to time (the “Purchase Agreement”). | form8k.htm |
| 2014-04-30 | 8-K | 2014-04-30 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 On April 30, 2014, Ashland Inc. (“Ashland”) announced preliminary second quarter results, which are discussed in more detail in the news release (the “News Release”) attached to this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1, which is incorporated by reference into this Item 2.02. 7.01 On April 30, 2014, Ashland will make available the News Release, a slide presentation and prepared remarks on the “Investor Center” section of Ashland’s website located at http://investor.ashland.com. | form8k.htm |
| 2014-04-22 | 8-K | 2014-04-21 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On April 22, 2014, Ashland Inc. announced that Chairman and Chief Executive Officer James J. O’Brien has decided to retire effective December 31, 2014 after 38 years of service to Ashland. | form8k.htm |
| 2014-04-14 | 8-K | 2014-04-08 | 1.01 Entry into a Material Definitive Agreement | 1.01 On April 8, 2014, Ashland Inc. (“Ashland”), Ashland International Holdings, Inc. (“Ashland International”), Clariant Produkte (Deutschland) GmbH (“Clariant Produkte” and, together with Ashland and Ashland International, the “Sellers”), Clariant Corp. (“Clariant Corp.”), mertus 158. | form8k.htm |
| 2014-04-09 | 8-K | 2014-04-09 | 8.01 Other Events | 8.01 On April 9, 2014, Ashland Inc. (“Ashland”) and Clariant announced that they have entered into a definitive agreement to sell their joint venture, ASK Chemicals GmbH headquartered in Hilden, Germany, to investment funds affiliated with Rhône, a London and New York-based private equity investment firm. | form8k.htm |
| 2014-02-24 | 8-K | 2014-02-18 | 1.01 Entry into a Material Definitive Agreement | 1.01 On February 18, 2014, Ashland Inc. (“Ashland”) and CD&R Seahawk Bidco, LLC (“Buyer”) entered into a Stock and Asset Purchase Agreement (the “Agreement”). | form-8k.htm |
| 2014-02-18 | 8-K | 2014-02-18 | 8.01 Other Events | 8.01 On February 18, 2014, Ashland Inc. (“Ashland”) announced that it has entered into a definitive agreement to sell its Ashland Water Technologies commercial unit to a fund managed by Clayton, Dubilier & Rice in a transaction valued at approximately $1.8 billion. | form8k.htm |
| 2014-02-04 | 8-K | 2014-01-30 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.07 Submission of Matters to a Vote of Security Holders | 5.02 As previously disclosed in the Proxy Statement filed by Ashland Inc. (“Ashland”) with the Securities and Exchange Commission on December 16, 2013 (the “Proxy Statement”), Kathleen Ligocki, a Class I director, retired from Ashland’s Board of Directors effective as of Ashland’s Annual Meeting of Shareholders on January 30, 2014 (the “Annual Meeting”). 5.03 As discussed under Item 5.07 of this Current Report on Form 8-K, at the Annual Meeting on January 30, 2014, the proposed amendment to Ashland’s Third Restated Articles of Incorporation to provide for the phased-in declassification of the Board of Directors (the “Amendment”) was approved by Ashland’s shareholders. 5.07 Ashland held its Annual Meeting on January 30, 2014. | form8k.htm |
| 2014-01-27 | 8-K | 2014-01-27 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 On January 27, 2014, Ashland Inc. (“Ashland”) announced preliminary first quarter results, which are discussed in more detail in the news release (the "News Release") attached to this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1, which is incorporated by reference into this Item 2.02. 7.01 On January 27, 2014, Ashland will make available the News Release, a slide presentation and prepared remarks on the “Investor Center” section of Ashland’s website located at http://investor.ashland.com. | form8k.htm |